• Company
• Byung-Jae Yoo to head integrated Novartis Korea
• by Eo, Yun-Ho Jul 8, 2022 06:25am

• Opinion
• [Reporter’s View] COVID-19 trials still in smooth progress?
• by Kim, Jin-Gu Jul 8, 2022 06:25am

• Company
• Dong-A ST prepares to make another leap with Actonel
• by Eo, Yun-Ho Jul 7, 2022 05:55am

• Company
• Two pharmaceutical unions unite with each other
• by Jul 7, 2022 05:54am

• Company
• First KRAS lung cancer drug Lumakras released next month
• by Jul 7, 2022 05:54am

• Company
• Novonodisk labor union announces union struggle on 7th
• by Eo, Yun-Ho Jul 7, 2022 05:54am

• Policy
• The MFDS announced the designation of 4 temporary narcotics
• by Lee, Hye-Kyung Jul 7, 2022 05:54am

• Company
• Next-gen breast cancer drug, pneumococcal vaccine to come
• by Jul 6, 2022 05:47am

• Opinion
• [Reporter's view] Revlimid passed the committee
• by Eo, Yun-Ho Jul 6, 2022 05:47am

• Company
• BL’s COVID-19 treatment expands indication to pneumonia
• by Lee, Seok-Jun Jul 6, 2022 05:47am